Aspire Capital Advisors LLC Bristol Myers Squibb CO Transaction History
Aspire Capital Advisors LLC
- $371 Million
- Q3 2025
A detailed history of Aspire Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aspire Capital Advisors LLC holds 11,209 shares of BMY stock, worth $524,693. This represents 0.14% of its overall portfolio holdings.
Number of Shares
11,209Holding current value
$524,693% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,683Shares Held
1.58BCall Options Held
28.2MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...